CD20 is a cell surface protein primarily expressed on the surface of B-cells, a type of white blood cell involved in the immune response. The CD20 molecule plays a critical role in the development, differentiation, and function of B-cells, which are responsible for producing antibodies. It acts as a calcium channel, helping regulate the flow of calcium ions into the cell, a process essential for B-cell activation and immune function. CD20 is not expressed on early B-cell precursors or on plasma cells, which means its expression is limited to specific stages in B-cell maturation.
Because CD20 is highly expressed on the surface of mature B-cells, it has become an important biomarker in diagnosing and treating various B-cell-related diseases, particularly B-cell non-Hodgkin lymphoma (NHL) and chronic lymphocytic leukemia (CLL). These cancers are characterized by an abnormal proliferation of B-cells, and CD20 serves as a target for therapies designed to eliminate these malignant cells. Rituximab, an anti-CD20 monoclonal antibody, was one of the first therapeutic agents to target this protein, marking a significant advance in cancer treatment.
In addition to its role in cancer treatment, CD20-targeted therapies are also used in autoimmune diseases like rheumatoid arthritis and multiple sclerosis. In these conditions, B-cells contribute to the overactive immune response, and by targeting CD20, therapies can reduce the number of B-cells, thus dampening the immune system’s activity. This strategy helps control inflammation and prevent the immune system from attacking the body's own tissues. CD20-targeted therapies are considered more selective, offering fewer side effects compared to broader immunosuppressive treatments.
Research continues to explore new ways to improve the effectiveness of CD20-targeted therapies. Studies are investigating different combinations of drugs and novel anti-CD20 agents to enhance patient outcomes. These advances hold promise for offering more personalized treatment options for patients suffering from B-cell malignancies and autoimmune diseases, underscoring the importance of CD20 as a pivotal biomarker in modern medicine.
Testing for CD20 is important because it helps identify whether B-cells, specifically in conditions like B-cell Non-Hodgkin Lymphoma (NHL) or chronic lymphocytic leukemia (CLL), express the CD20 protein on their surface. This information is crucial for diagnosis and treatment planning, as CD20-positive B-cells can be targeted by specific therapies, such as monoclonal antibodies like Rituximab. These therapies directly attack the malignant B-cells, improving treatment outcomes. Additionally, CD20 testing helps distinguish different subtypes of lymphomas and guides personalized treatment strategies.
All Your Lab Results.
One Simple Dashboard.
Import, Track, and Share Your Lab Results Easily
Import, Track, and Share Your Lab Results
Import lab results from multiple providers, track changes over time, customize your reference ranges, and get clear explanations for each result. Everything is stored securely, exportable in one organized file, and shareable with your doctor—or anyone you choose.
Cancel or upgrade anytime
What does it mean if your CD20, Abs Count result is too low?
Decreased CD20 Absolute Count
A reduction in CD20+ B lymphocytes in the bloodstream can have various implications, depending on the underlying cause.
Potential Causes
-
B Cell Depletion Therapy
- Anti-CD20 treatments, such as rituximab or obinutuzumab, used for conditions like non-Hodgkin lymphoma, chronic lymphocytic leukemia, and autoimmune diseases.
-
Immunodeficiencies
- Primary or secondary conditions affecting B cell production or survival, including common variable immunodeficiency (CVID) or HIV/AIDS.
-
Bone Marrow Disorders
- Conditions impairing B cell production, such as aplastic anemia or myelodysplastic syndromes.
-
B Cell Maturation Defects
- Genetic or acquired defects that hinder normal B cell development.
-
Post-Infectious or Inflammatory States
- Temporary reductions caused by immune system activity or B cell sequestration in lymphoid tissues during infections or inflammation.
-
Malignant Disorders
- Certain B cell malignancies, such as lymphomas or leukemias, may exhibit decreased CD20 expression or reduced B cell counts.
Evaluation and Next Steps
If the CD20 Absolute Count is decreased, further assessment should include:
- Complete Blood Count (CBC): To assess overall lymphocyte levels.
- Flow Cytometry Panel: To evaluate other B cell markers and identify abnormalities.
- Bone Marrow Biopsy: If bone marrow disorders are suspected.
- Clinical Correlation: A thorough review of symptoms, medical history, and recent treatments.
Interpretation:
Decreased CD20 Absolute Count must be interpreted in the context of clinical findings to guide diagnosis and management effectively.
Laboratories
Bring All Your Lab Results Together — In One Place
We accept reports from any lab, so you can easily collect and organize all your health information in one secure spot.
Pricing Table
Gather Your Lab History — and Finally Make Sense of It
Finally, Your Lab Results Organized and Clear
Personal plans
$79/ year
Advanced Plan
Access your lab reports, explanations, and tracking tools.
- Import lab results from any provider
- Track all results with visual tools
- Customize your reference ranges
- Export your full lab history anytime
- Share results securely with anyone
- Receive 5 reports entered for you
- Cancel or upgrade anytime
$250/ once
Unlimited Account
Pay once, access everything—no monthly fees, no limits.
- Import lab results from any provider
- Track all results with visual tools
- Customize your reference ranges
- Export your full lab history anytime
- Share results securely with anyone
- Receive 10 reports entered for you
- No subscriptions. No extra fees.
$45/ month
Pro Monthly
Designed for professionals managing their clients' lab reports
- Import lab results from any provider
- Track lab results for multiple clients
- Customize reference ranges per client
- Export lab histories and reports
- Begin with first report entered by us
- Cancel or upgrade anytime
About membership
What's included in a Healthmatters membership
Import Lab Results from Any Source
See Your Health Timeline
Understand What Your Results Mean
Visualize Your Results
Data Entry Service for Your Reports
Securely Share With Anyone You Trust
Let Your Lab Results Tell the Full Story
Once your results are in one place, see the bigger picture — track trends over time, compare data side by side, export your full history, and share securely with anyone you trust.
Bring all your results together to compare, track progress, export your history, and share securely.
What Healthmatters Members Are Saying
Frequently asked questions
Healthmatters is a personal health dashboard that helps you organize and understand your lab results. It collects and displays your medical test data from any lab in one secure, easy-to-use platform.
- Individuals who want to track and understand their health over time.
- Health professionals, such as doctors, nutritionists, and wellness coaches, need to manage and interpret lab data for their clients.
With a Healthmatters account, you can:
- Upload lab reports from any lab
- View your data in interactive graphs, tables, and timelines
- Track trends and monitor changes over time
- Customize your reference ranges
- Export and share your full lab history
- Access your results anytime, from any device
Professionals can also analyze client data more efficiently and save time managing lab reports.
Healthmatters.io personal account provides in-depth research on 10000+ biomarkers, including information and suggestions for test panels such as, but not limited to:
- The GI Effects® Comprehensive Stool Profile,
- GI-MAP,
- The NutrEval FMV®,
- The ION Profile,
- Amino Acids Profile,
- Dried Urine Test for Comprehensive Hormones (DUTCH),
- Organic Acids Test,
- Organix Comprehensive Profile,
- Toxic Metals,
- Complete Blood Count (CBC),
- Metabolic panel,
- Thyroid panel,
- Lipid Panel,
- Urinalysis,
- And many, many more.
You can combine all test reports inside your Healthmatters account and keep them in one place. It gives you an excellent overview of all your health data. Once you retest, you can add new results and compare them.
If you are still determining whether Healthmatters support your lab results, the rule is that if you can test it, you can upload it to Healthmatters.
We implement proven measures to keep your data safe.
At HealthMatters, we're committed to maintaining the security and confidentiality of your personal information. We've put industry-leading security standards in place to help protect against the loss, misuse, or alteration of the information under our control. We use procedural, physical, and electronic security methods designed to prevent unauthorized people from getting access to this information. Our internal code of conduct adds additional privacy protection. All data is backed up multiple times a day and encrypted using SSL certificates. See our Privacy Policy for more details.